Corporate Management

Mr. ZHONG Ming (钟鸣) is one of the founders of our Group. He was appointed as an executive director and served as the Chairman of the Board, and the chief executive officer of our Company. Mr. Zhong is mainly responsible for overall management of the business, strategy and corporate development of the Group. Since he founded our Group together with Ms. Shentu in August 2004, he has held the positions of the general manager and the chairman of the board at Hangzhou Kangji. Mr. Zhong has served as a vice president at Surgery Medical Equipment Branch of China Association of Medical Equipment (中国医学装备协会外科医学装备分会) since July 2016.

Mr. Zhong received his bachelor’s degree in business administration (part-time) from China University of Geosciences (中国地质大学) in the PRC in January 2006. Mr. Zhong was awarded the Outstanding Hangzhou Entrepreneur (杰出杭商) by World Hangzhou Entrepreneur Convention (世界杭商大会) held by The People’s Government of Hangzhou City (杭州市人民政府) in 2018, and was awarded Outstanding T-Merchants (杰出桐商) by Conference of T-Merchants (桐商大会) held by The People’s Government of Tonglu County (桐庐县人民政府) in 2016.

Ms. SHENTU Yinguang (申屠銀光) is one of the founders of our Group. She was appointed as an executive director and served as the vice general manager of our Company. Ms. Shentu is mainly responsible for overall management of the business, strategy and corporate development of the Group. Since the inception of our Group in August 2004, Ms. Shentu has held the positions of the vice general manager and the vice chairman of the board at Hangzhou Kangji.

Ms. Shentu received her college degree in accounting (part-time) from China University of Geosciences (中国地质大学) in the PRC in August 2005. Ms. Shentu was awarded the Top Ten Innovation Women in Zhejiang (浙江十大创新女杰) by Zhejiang High-tech Enterprise Association (浙江省高新技术企业协会), Zhejiang Women Entrepreneur Association (浙江省女企业家协会), Zhejiang Scientific and Technological Innovation Entrepreneur Promotion Association (浙江省科技新浙商促进会), Zhejiang Technological and Innovative Enterprise Association (浙江省科技创新企业协会) and Sci-tech and Finance Times (科技金融时报) in 2019, the Tonglu Entrepreneur of the Year (年度桐庐企业家) by The People’s Government of Tonglu County (桐庐县人民政府) in December 2019, and the Outstanding Hangzhou Entrepreneur Award (风云杭商奖) by Hangzhou Internationalization Innovation Forum (杭州国际化创新论坛) jointly held by Hang Zhou Culture Radio Television Group (杭州文广集团), Hangzhou Federation of Industry and Commerce (杭州市工商业联合会), Hangzhou Municipal Bureau of Commerce (杭州市商务局) and several other governmental entities in January 2020. Ms. Shentu has also been a member of Chinese People’s Political Consultative Conference of Tonglu County (桐庐县政协) since January 2007.

Ms. Hu, aged 46, has more than 15 years of ample experience in enterprise value management, financial management and investment management. She worked at Sunny Optical Technology (Group) Company Limited (stock code: 2382), a company listed on the Stock Exchange, as the director of investors’ relation from January 2008 to November 2013, and as the secretary to the board of directors and a joint company secretary from November 2010 to November 2013. Ms. Hu has been a managing director of Shenzhen Eastern Marathon Investment Management Company Limited*（深圳市東方馬拉松投資管理有限公司） from March 2017 to May 2019, and she subsequently worked in the field of private investment fund management. Ms. Hu obtained her master’s degree in business administration from Shanghai University of Finance and Economics in April 2008 and a bachelor’s degree in business administration from Zhejiang University in July 2003. She has also obtained the qualification of economist issued by Personnel Bureau of Hangzhou in 2008.

Mr. YIN Zixin (尹自鑫) was appointed as our vice general manager and one of our joint company secretaries on March 7, 2020，he was appointed as an executive director on April 28, 2022. Mr. Yin joined the Group in September 2016 as a general manager assistant and has acted as the secretary to the board since November 8, 2016 at Hangzhou Kangji Medical Instrument Ltd.（杭州康基醫療器械有限公司）(“Hangzhou Kangji”), an indirect wholly-owned subsidiary of the Company. Mr. Yin has been a director at Hangzhou Kangji since August 2020 and a director at Hangzhou Weijing Medical Robot Co., Ltd.（杭州唯精醫療機器人有限公司）(“Hangzhou Weijing”) since February 2022. Hangzhou Weijing will be held as to 35% by Kangji Medical (Hong Kong) Limited upon completion of the investment as disclosed in the announcement of the Company dated January 18, 2022. Mr. Yin is mainly responsible for investor relationships, investment and corporate governance matters of the Group.

Before joining our Group, from July 2008 to October 2010, Mr. Yin served as a department manager at Hangzhou Yingce Enterprise Management and Consultation Co., Ltd. (杭州英策企业管理咨询有限公司), where he was primarily responsible for product and business development. From November 2010 to August 2016, Mr. Yin worked as an investment manager and assistant to the chairman of the board at Wanma United Holding Group Co., Ltd. (万马联合控股集团有限公司), where he was primarily responsible for investment and M&A.

Mr. Yin received his bachelor’s degree in economics and management from Zhejiang University of Finance & Economics (浙江财经大学) in the PRC in June 2008.

Mr. CHENG Da (程达) was appointed as our vice general manager on March 1,
2011. Mr. Cheng joined our Group in March 2011 and has worked as a vice general manager at Hangzhou Kangji. Mr. Cheng is primarily responsible for sales management of our Group.

Before joining our Group, Mr. Cheng served as a department head at Terumo Medical Products (Hangzhou) Co., Ltd. (泰尔茂医疗产品(杭州)有限公司) from July 2001 to February 2006, where he was mainly responsible for technology management and product development. From March 2006 to February 2011, Mr. Cheng served as a vice general manager at Hangzhou Fushan Medical Appliances Co., Ltd. (杭州富善医疗器械有限公司), where he was primarily responsible for establishing and maintaining company quality control system and managing technology and quality department.

Mr. Cheng received his bachelor’s degree in chemistry from Nankai University (南开大学) in the PRC in June 2001

Mr. YUE Jiqiang (岳计强) was appointed as our vice general manager on May 16, 2009. Mr. Yue joined our Group in May 2009 and has worked as a vice general manager at Hangzhou Kangji. Mr. Yue is mainly responsible for research and development of our Group.

From September 2002 to February 2004, Mr. Yue served as a manager at Hangzhou Kangyou Medical Equipment Co., Ltd. (杭州康友医疗设备有限公司), where he was primarily responsible for research and development. From December 2004 to April 2009, Mr. Yue served as a manager at Hangzhou Optcla Medical Instrument Co., Ltd. (杭州光典医疗器械有限公司), where he was primarily responsible for research and
development.

Mr. Yue received his college degree in machine manufacturing from Huabei Mechanical and Electrical Secondary School (华北机电学校) in the PRC in June 2001.

Mr. TANG Wenpeng (唐文鹏) was appointed as our vice general manager on March 5, 2018. Mr. Tang joined our Group in March 2017 and has worked as a vice general manager and manager of quality control department at Hangzhou Kangji. Mr. Tang is mainly responsible for production and quality control of our Group.

Mr. Tang served as a department head at Terumo Medical Product (Hangzhou) Co., Ltd. (泰尔茂医疗产品(杭州)有限公司), where he was primarily responsible for quality control, from April 2000 to September 2009. From October 2009 to March 2017, Mr. Tang served as a vice general manager at Jiangxi Fenglin Medical Device Co., Ltd. (江西丰临医用器械有限公司), where he was mainly responsible for production and quality control.

Mr. Tang received his bachelor’s degree in polymer materials from Shanghai Jiao Tong University (上海交通大学) in the PRC in July 1996.

Mr. JU Jianyong (雎建勇) joined the Group on January 1, 2021 as head of domestic sales and marketing. Mr. Ju began his career as a clinician in pediatrics, and then moved to work in sales in the medical industry.

Mr. Ju has extensive expertise in academic promotions across multiple specialties such as obstetrics and gynaecology, urology, oncology, and pediatrics. Prior to joining the Group, Mr. Ju worked in Nanjing Dongyuan Pharmaceutical Co., Ltd. (南京东元制药有限公司）, Beecham Group, Hainan Zambon Pharmaceutical Co.,Ltd (海南赞邦制药有限公司), Beijing Biote Pharmaceutical Co., Ltd (北京博恩特药业有限公司) and served a series of sales positions, including sales representative, district sales manager, regional manager, sales director and head of sales and marketing, mainly responsible for leading sales team and product promotion and marketing work.

Mr. Ju graduated from Anhui Medical University (安徽医科大学) with a bachelor’s degree in clinical medicine in 1998.

Ms. Frances Fang CHOVANEC was appointed as our chief financial officer on March 7, 2020, and appointed as executive director on November 5, 2020. Ms. Chovanec is primarily responsible for the management of financial affairs and investor relations of our Group.

Ms. Chovanec has extensive experience in the finance industry and worked at well-known investment banks for more than 12 years. From 2000 through 2014, Ms. Chovanec had successively served as an analyst at JPMorgan Chase & Company, as an associate and then a vice president at Morgan Stanley Asia Limited and an executive director in the investment banking division of Goldman Sachs & Company, where she had extensively involved in investment banking transaction execution and client coverage. From October 2014 to October 2015, Ms. Chovanec served as a director at Teneo Capital, LLC, a company engaged in investment banking, where she focused on M&A transaction execution. From November 2015 to December 2016, Ms. Chovanec was employed as a managing director by Evercore Management Corporation of Fosun Group where she was mainly focused on private equity investment and portfolio management. Since January 2017, Ms. Chovanec provided consulting services to clients through her own firm, Bird’s Nest Advisors, LLC, and mainly advised on strategic partnership, licensing and business development projects. One such example was that she served as an executive vice president at TECLens, LLC, a medical device company focusing on the refractive correction market.

Ms. Chovanec received her bachelor’s degree in finance from University of Bridgeport in the U.S. in May 2000 and master’s degree in business administration from the Wharton School of the University of Pennsylvania in the U.S. in May 2005. Ms. Chovanec is a Chartered Financial Analyst (CFA) and she obtained the qualification from the Chartered Financial Analyst Institute in July 2003. Ms. Frances Fang Chovanec (“Ms. Chovanec”) has tendered her resignation as an executive Director, the Chief Financial Officer of the Company and a member of the Company’s environmental, social and governance committee with effect from September 15, 2023. Ms. Chovanec will be engaged as a consultant to the Company with effect from September 15, 2023.